Minnesota legislation · 94th Legislature 2025-2026
Minnesota SF5290: Addition requirement for certain pharmaceutical marketing expenses
Status: In committee, May 13, 2026
What the bill says
A bill for an act relating to taxation; individual income and corporate franchise tax; requiring an addition for certain pharmaceutical marketing expenses; amending Minnesota Statutes 2024, sections 290.0131, by adding a subdivision; 290.0133, by adding a subdivision.
From the introduced text, May 12, 2026:
A bill for an act relating to taxation; individual income and corporate franchise tax; requiring an addition for certain pharmaceutical marketing expenses; amending Minnesota Statutes 2024, sections 290.0131, by adding a subdivision; 290.0133, by adding a subdivision. Section 1. Minnesota Statutes 2024, section 290.0131, is amended by adding a subdivision to read: new text begin [ADDED: Subd. 21.] new text end new text begin [ADDED: Pharmaceutical marketing expenses.] new text end new text begin [ADDED: (a) For the purposes of this subdivision, the following terms have the meanings given:] new text end new text begin [ and] new text end new text begin [ADDED: (2) "pharmaceutical manufacturer" means a person or entity engaged in the production, preparation, propagation, compounding, or processing of prescription drugs or biologics.] new text end new text begin [ADDED: (b) The amount deducted under section 162 of the Internal Revenue Code for direct-to-consumer pharmaceutical marketing is an addition.] new text end new text begin [ADDED: EFFECTIVE DATE.] new text end new text begin [ADDED: This section is effective for taxable years beginning after December 31, 2026.] new text end Sec. 2. Minnesota Statutes 2024, section 290.0133, is amended by adding a subdivision to read: new text begin [ADDED: Subd. 16.] new text end new text begin [ADDED: Pharmaceutical marketing expenses.] new text end new text begin …
Sponsors
- Matt Klein (D) · primary sponsor
Latest actions
- : Referred to Taxes
- : Introduction and first reading
Common questions
- What is SF5290?
- SF5290 is a bill in the Minnesota Legislature (94th Legislature 2025-2026): Addition requirement for certain pharmaceutical marketing expenses.
- What does SF5290 do?
- In its own words: A bill for an act relating to taxation; individual income and corporate franchise tax; requiring an addition for certain pharmaceutical marketing expenses; amending Minnesota Statutes 2024, sections 290.0131, by adding a subdivision; 290.0133, by adding a subdivision.
- What is the status of SF5290?
- In committee as of May 13, 2026. Latest action: Referred to Taxes (May 13, 2026).
- Who sponsored SF5290?
- Matt Klein (D).
- Where is the official record for SF5290?
- On the Minnesota Legislature website: https://www.revisor.mn.gov/bills/bill.php?f=SF5290&y=2025&ssn=0&b=senate
Source: official Minnesota record. Tracked by Delilah, AI for legislation across all 50 states and Congress.